Ipatimup

Announcements
- Jobs
Market Consultation
About Ipatimup
- Brief History
- Organization
- Institutional Reports
- Documents
- Protocols
- Contacts
- Top n Papers
Research
- Cancer Drug Resistance
- Cancer Metastasis
- Cancer Signalling & Metabolism
- Cytoskeleton Regulation and Cancer
- Differentiation and cancer
- Expression Regulation in Cancer
- Genetic Diversity
- Glycobiology in Cancer
- Immunology, Cancer and Glycomedicine
- Intercellular Communication and Cancer
- Microbes & Cancer
- Population Genetics
- Projects
- Papers
- Scientific Equipment
Outreach Activities
- Cancer Prevention
- Public Awareness of Cancer
Services
- Animal Model Facility
- GenCore
- In vivo CAM Assays
- Ipatimup Diagnostics
- Proteomics
- Slides Digitalization Service
Innovation & Translation
- Ipatimup Innovation
- Ipatimup Translational Research
Digital Microscopy Applications
Equinox Conference
Porto Cancer Meeting
Portugaliæ Genetica
Privacy Policy
Cookie Policy
Whistleblower Channel

Paper Detail

Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F

XRCC1 Arg399Gln and RAD51 5'UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients. Breast cancer research and treatment 109: 183-5, 2008. [Letter]

doi: 10.1007/s10549-007-9637-1 PMID: 17616806.

5.7

@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto